Logo-npj
Submitted: 02 Oct 2023
Accepted: 05 Nov 2023
ePublished: 29 Nov 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2024;13(1): e11648.
doi: 10.34172/npj.2023.11648
  Abstract View: 567
  PDF Download: 202

Letter to Editor

Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology

Samaneh Zandifar 1 ORCID logo, Sadaf Farnam Nia 1 ORCID logo, Rastina Mehrani 2 ORCID logo, Bina Bakhshaei 3 ORCID logo, Samin Karamian 4* ORCID logo, Sina Bagheri 5 ORCID logo, Ali Ghorbani 5, Sina Bakhshaei 6* ORCID logo

1 Nickan Research Institute, Isfahan, Iran
2 School of Medicine, St George University, Grenada
3 Neurology Department, Median Klinik NRZ, Wiesbaden, Germany
4 Emergency Department, Parsian Hospital, Shahrekord, Iran
5 Internal Medicine Department, UHS Southwest Medical Education Consortium Temecula, CA, USA
6 Cardiology Department, UHS Southwest Medical Education Consortium Temecula, CA, USA
*Corresponding Authors: Samin Karamian, Email: karamian.samin@yahoo.com; Sina Bakhshaei, Email: sina.bakhshaei@uhsinc.com

Implication for health policy/practice/research/medical education:

Reverse cardio-oncology addressed the risk of ensuing cancer in individuals with heart disease. It is imperative to collaborate oncology with cardiology to effectively prevent and treat related diseases.

Please cite this paper as: Zandifar S, Farnam Nia S, Mehrani R, Bakhshaei B, Karamian S, Bagheri S, Ghorbani A, Bakhshaei S. Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology. J Nephropharmacol. 2024;13(1):e11648. DOI: 10.34172/npj.2023.11648.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 568

Your browser does not support the canvas element.


PDF Download: 202

Your browser does not support the canvas element.